期刊文献+

血管活性肠肽对内毒素性休克大鼠肠道TLR4、MD2和BD3 mRNA表达的影响

Effect of vasoactive intestinal peptide on intestinal TLR4,MD2 and BD3 expression in rats with endotoxic shock
下载PDF
导出
摘要 目的探讨血管活性肠肽(vasoactive intestinal peptide,VIP)对细菌脂多糖(lipopolysaccharide,LPS)致休克大鼠肠道组织TLR4、MD2和BD3 mRNA表达的影响。方法 40只SD大鼠,随机分为LPS组(15只)、LPS+VIP组(15只)和对照组(10只)。LPS组尾静脉注射LPS(E.coli O55B5)10 mg/kg;LPS+VIP组尾静脉注射LPS 10 mg/kg后注射VIP 5 nmol/kg;对照组尾静脉注射等容量生理盐水。分别于注射后6 h和24 h处死,留取结肠组织标本,RT-PCR检测结肠组织TLR4、MD2和BD3 mRNA表达,光镜下观察24 h时肠组织病理变化。结果①肠组织病理改变:注射LPS后大鼠肠黏膜坏死脱落,微绒毛结构消失,结缔组织明显充血,大量的炎性细胞浸润。采用VIP治疗后病变明显减轻。②TLR4、MD2和BD3 mRNA表达:注射VIP后6 h、24 h,肠组织TLR4、MD2和BD3 mRNA表达升高(P<0.05);24 h时LPS+VIP组TLR4、BD3和MD2 mRNA表达明显低于LPS组(P<0.05)。结论 LPS致内毒素性休克大鼠肠道损伤时,肠组织TLR4、MD2和BD3 mRNA表达增强。VIP可减轻LPS所致肠道黏膜损伤,其机制可能与下调重要的炎症基因TLR4、MD2和BD3 mRNA表达有关。 Objective To investigate the effect of vasoactive intestinal peptide (VIP) on TLR4,MD2 and BD3 mRNA expression in endotoxin (lipopolysaccharide,LPS) induced shock.Methods Forty Sprague-Dawley rats were randomly divided into 3 groups:LPS shock group (n =15),LPS + VIP group (n =15),and control group (n =10).LPS shock model was established by LPS (E.coli O55B5 10 mg/kg) with tail intravenous injection.The rats in LPS + VIP group were given VIP intravenous injection (5 nmol/kg) followed by LPS,the rats in control group were given normal saline.The rats were sacrificed at 6 h,24 h after being injected.The colon tissues were collected.The TLR4,MD2 and BD3 mRNA expression were detected by RT-PCR from the colon tissues.Pathological changes of the colon tissues were observed by microscope 24 h after LPS injection.Results ① Intestinal mucosa showed edema or necrotic change with structure of the microvilli disappeared after LPS injection.The inestinal lesion in LPS + VIP group were milder than LPS group.② The expression of TLR4,MD2 and BD3 mRNA were significantly higher in LPS shock group compared with those of the control group (P < 0.05).TLR4,MD2 and BD3 mRNA expression on 24 h was down regulated in LPS + VIP shock subgroup than those in LPS shock subgroup (P < 0.05).Conclusion Expression of TLR4,MD2 and BD3 mRNA were up-regulated on LPS induced intestinal colitis in rats.VIP mitigated intestinal injury by LPS,which may be related to TLR4,MD2 and BD3 mRNA down-regulation of expression.The effect of VIP may suggest a protective mechanism in severe infection.
出处 《胃肠病学和肝病学杂志》 CAS 2014年第6期632-635,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 血管活性肠肽 内毒素性休克 TOLL样受体4 髓样分化蛋白2 β-防御素-3 肠组织 Vasoactive intestinal peptide Lipopolysaccharide shock Toll-like receptor 4 Mreloid differential protein 2 β-defensin-3 Intestine
  • 相关文献

参考文献6

  • 1Gomariz RP, Martinez C, Abad C, et al. Immunology of VIP: a review and therapeutical perspectives L JJ. Curt Pharm Des, 2001, 7(2): 89-111.
  • 2Delgado M, Pozo D, Ganea D. The significance of vasoactive intestinal peptide in immunomodulation [ J ]. Pharmacol Rev, 2004, 56 (2) : 249 -290.
  • 3杨丽萍,张育才,汤定华,滕国良,张宇鸣.血管活性肠肽对内毒素性休克大鼠肺损伤的保护作用[J].中华急诊医学杂志,2008,17(9):952-955. 被引量:3
  • 4Lenoir C, Sapin C, Broquet AH, et al. MD-2 controls bacterial lipopo- lysaccharide hyporesponsiveness in human intestinal epithelial cells [ J ]. Life Sci, 2008, 82(9-10): 519-528.
  • 5Btcker U, Yezerskyy O, Feiek P, et al. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like re- ceptor 4 but not Toll-like receptor 2 or CD14 expression [ J]. Int J Co]orectal Dis, 2003, 18( 1 ) : 25-32.
  • 6Amid C, Rehaume LM, Brown KL, et al. Manual annotation and anal- ysis of the defensin 8ene cluster in the C57BL/6J mouse reference ge- home [J]. BMC Genomics, 2009, 10i 606.

二级参考文献14

  • 1杨丽萍,张育才.血管活性肠肽和垂体腺苷酸环化酶激肽在感染性休克中的作用[J].国外医学(儿科学分册),2005,32(2):74-76. 被引量:1
  • 2张育才,杨丽萍,汤定华,张宇鸣.血管活性肠肽对大鼠内毒素性休克肠道损伤保护作用的研究[J].中华儿科杂志,2006,44(5):369-373. 被引量:19
  • 3Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed wth time? [J]. Crit Care Med, 1998,26(12):2078-2086.
  • 4Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidlines for management of severe sepsis and septic shock[J]. Crit Care Med, 2004,32(3) :858-873.
  • 5Ware LB. Pathophysiology of acute lung injury [ J ]. Semin Respir Crit Care Med, 2001,22(3) :247-258.
  • 6Frevert CW, Martin TR. Sepsis and the lung host response[J]. Semin Respir Crit Care Med, 2004,25 ( 1 ) : 85-93.
  • 7Pozo D, Delgado M, Martinez C, et al. Immunbiology of vasoactive intestinal peptide(VIP) [J]. Immunology Today, 2000, 21( 1 ) :7-11.
  • 8Ganea D, Delgado M. The neuropeptides VIP/PACAP and T cells: inhibitors or activators? [J]. Curr Pharm Des, 2003,9(12): 997-1004.
  • 9Delgado M, Munoz-Elias EJ,Gomarize RP,et al. VIP and PACAP prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-tcB and interferon regulatory factor 1 activation [ J ]. J Immunol, 1999,162(8) :4685-4696.
  • 10Ganea D, Delgado M. Neuropeptides as modulators of macrophage functions:regulation of cytokine production and antigen presentation by VIP and PACAP[J]. Arch Immunol Ther Exp(Warsz),2001,49(2) : 101- 110.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部